NOVIGENIX

Serial Number 98976186
748

Registration Progress

Application Filed
Dec 22, 2023
Under Examination
Nov 19, 2024
Approved for Publication
Sep 24, 2024
Published for Opposition
Sep 24, 2024
Registered

Attorney Assistance

Statement of Use Due - Extension 1 Granted
Due: Nov 19, 2025 112 days

Trademark Image

NOVIGENIX

Basic Information

Serial Number
98976186
Filing Date
December 22, 2023
Published for Opposition
September 24, 2024
Drawing Code
4

Status Summary

Current Status
Active
Status Code
748
Status Date
Jun 25, 2025
Application
Pending
Classes
042

Rights Holder

Novigenix SA

33
Address
Route de la Corniche 3
Epalinges 1066
CH

Ownership History

Novigenix SA

Original Applicant
33
Epalinges CH

Novigenix SA

Owner at Publication
33
Epalinges CH

Legal Representation

Attorney
Raffi Zerounian

USPTO Deadlines

Next Deadline
112 days remaining
Statement of Use Due - Extension 1 Granted
Due Date
November 19, 2025
Extension Available
Until November 19, 2025

Application History

26 events
Date Code Type Description Documents
Jun 25, 2025 CORV P REVIEW OF CORRESPONDENCE COMPLETE Loading...
Jun 25, 2025 DPCC D DIVISIONAL PROCESSING COMPLETE Loading...
Jun 25, 2025 EX1G S SOU EXTENSION 1 GRANTED Loading...
Jun 25, 2025 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Jun 18, 2025 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Feb 4, 2025 ERTD I TEAS REQUEST TO DIVIDE RECEIVED Loading...
Feb 3, 2025 ERTD I TEAS REQUEST TO DIVIDE RECEIVED Loading...
Feb 3, 2025 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Feb 3, 2025 IUAF S USE AMENDMENT FILED Loading...
Feb 3, 2025 DRRR I DIVISIONAL REQUEST RECEIVED Loading...
Jan 27, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jan 27, 2025 EXT1 S SOU EXTENSION 1 FILED Loading...
Nov 19, 2024 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Sep 24, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Sep 24, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
Sep 4, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Aug 20, 2024 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Aug 16, 2024 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Aug 15, 2024 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Aug 15, 2024 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jul 29, 2024 GNRT F NON-FINAL ACTION E-MAILED Loading...
Jul 29, 2024 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jul 29, 2024 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jul 24, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
Apr 5, 2024 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Dec 22, 2023 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 042
Pharmaceutical research services; clinical research in the fields of immunotherapy and drug development; medical and scientific research, namely, conducting, clinical trials for others; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; blood analysis services for scientific research purposes
First Use Anywhere: Jan 24, 2024
First Use in Commerce: Jan 24, 2024

Classification

International Classes
042